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SUMMARY
Channelrhodopsin2 (ChR2) optogenetic excitation is widely used to study neurons, astrocytes, and 
circuits. Using complementary approaches in situ and in vivo, we found that ChR2 stimulation 
leads to significant transient elevation of extracellular potassium ions by ~5 mM. Such elevations 
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were detected in ChR2-expressing mice, following local in vivo expression of ChR2(H134R) with 
adeno-associated viruses (AAVs), in different brain areas and when ChR2 was expressed in 
neurons or astrocytes. In particular, ChR2-mediated excitation of striatal astrocytes was sufficient 
to increase medium spiny neuron (MSN) excitability and immediate early gene expression. The 
effects on MSN excitability were recapitulated in silico with a computational MSN model and 
detected in vivo as increased action potential firing in awake, behaving mice. We show that 
transient, physiologically consequential increases in extracellular potassium ions accompany 
ChR2 optogenetic excitation. This coincidental effect may be important to consider during 
astrocyte studies employing ChR2 to interrogate neural circuits and animal behavior.
In Brief
Using multiple approaches, Octeau et al. discover that optogenetic excitation of ChR2-expressing 
cells leads to significant transient extracellular potassium ion elevations that increase neuronal 
excitability and immediate early gene expression in neurons following in vivo stimulation.
Graphical Abstract
INTRODUCTION
The emergent field of optogenetics has revolutionized neuroscience since the landmark 
discovery that optical stimulation of channelrhodopsin2 (ChR2)-expressing cells elicits 
membrane potential depolarization (Nagel et al., 2003) and by the subsequent demonstration 
that such responses can be used to evoke action potential (AP) firing in neurons (Boyden et 
al., 2005). ChR2 and its variants are now widely used to explore neurons, glia, and multiple 
other cell types, permitting straightforward optical stimulation of genetically targeted cell 
populations and exploration of their contributions to neural circuit properties and animal 
behaviors (Bernstein and Boyden, 2011; Deisseroth, 2015).
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The usual interpretation of neuronal studies that employ ChR2 is that selective, brief optical 
excitation of the targeted neurons causes sufficient membrane depolarization to engage 
endogenous voltage-gated ion channels and lead to AP firing in ChR2- expressing neurons, 
which then may cause ensuing changes in neural circuits controlling behavior. Thus, ChR2 
provides an initial depolarizing inward current to bring the neurons to threshold. In this way, 
ChR2 has become a powerful tool for functional interrogation of neural circuits in vivo in a 
multitude of scenarios (Bernstein and Boyden, 2011; Deisseroth, 2015). Given its ease of 
use, ChR2-mediated excitation has also been used in a similar manner to explore the roles of 
astrocytes in regulating mouse behavior and circuits. For example, ChR2- driven astrocyte 
excitation has been used to implicate astrocytes in breathing (Gourine et al., 2010), response 
selectivity in the visual cortex (Perea et al., 2014), regulation of blood flow (Masamoto et 
al., 2015), sleep (Pelluru et al., 2016; Yamashita et al., 2014), and cerebellar motor function 
(Sasaki et al., 2012). It has also been used to regulate neuronal activity by engaging 
astrocyte mechanisms (Deemyad et al., 2018; Mederos et al., 2019; Shen et al., 2017) and to 
mimic the effects of neuronal activity on astrocyte glutamate transport (Gomez et al., 2019). 
However, astrocytes have few if any voltage-gated ion channels and display no propagated 
voltage signals. In the absence of a physiologically relevant endogenous voltage-dependent 
excitability mechanism to engage following brief ChR2 stimulation, several astrocyte studies 
have instead used quite long periods of ChR2 stimulation lasting from seconds to tens of 
seconds in order to observe subsequent effects on single neurons, circuits, and, in some 
cases, animal behavior. In some of these cases, ChR2-mediated excitation of astrocytes has 
suggested that astrocytes regulate circuits via gliotransmission, which was evoked by optical 
stimulation (Bang et al., 2016; Figueiredo et al., 2011).
We have been exploring astrocyte-neuron interactions in striatal microcircuits (Chai et al., 
2017; Jiang et al., 2016; Octeau et al., 2018a; Srinivasan et al., 2016; Tong et al., 2014; Yu et 
al., 2018). As part of this, buoyed by the aforementioned studies, we used Thy1-ChR2-YFP 
mice (Arenkiel et al., 2007) to drive trains of APs in premotor cortical neurons and to study 
the consequences of this increased excitation upon striatal MSNs and astrocytes. However, 
during the experiments, we identified an unexpected slow inward current in both striatal 
medium spiny neurons (MSNs) and, surprisingly, in astrocytes. We describe the properties of 
the slow inward current and subsequent experiments that suggested that it was due to release 
of K+ into the extracellular space, which we carefully explored. The data reveal a potentially 
important consequence of ChR2-mediated optogenetic excitation, which is likely an 
important confounding feature for astrocyte studies employing prolonged ChR2 stimulation, 
especially for behavioral experiments where electrophysiological studies are not performed. 
Elevated K+ is expected to affect the physiology of not only neurons, but also diverse brain 
cell types (McDonough and Youn, 2017), as well as affect local blood flow and functional 
hyperemia (Girouard et al., 2010). These could influence the interpretation of, and possibly 
even cause, endpoint measures at different temporal scales, especially in vivo, in studies that 
employ ChR2 in astrocytes.
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RESULTS
Transient Extracellular K+ Elevations during Optical Stimulation in Thy1-ChR2-YFP Mice
ChR2 and its variants are the most commonly used tools for optogenetic excitation (Zhang et 
al., 2011). Immunohistochemistry (IHC) revealed strong expression of ChR2-YFP in Thy1-
ChR2-YFP mice (Arenkiel et al., 2007) with strong expression in layer V cortical neurons 
(Figure 1A; n = 3 mice). As expected with the Thy1 promoter, there was little expression in 
the striatum (Figure 1A), but at higher magnification, there was strong colocalization 
between ChR2-YFP and neurofilament (Nflm) in corticostriatal white matter tracts, but no 
significant colocalization between ChR2-YFP and neuronal nuclei (NeuN) or with the 
astrocyte marker S100β (Figures 1B and 1C; n = 12 images, n = 4 mice). Next, we recorded 
in whole-cell voltage-clamp mode from MSNs in sagittal brain slices and employed wide-
field optical stimulation using parameters comparable to those used in vivo (Gibson et al., 
2014). We used 473 nm light, ~0.02 mW/mm2 power, and 25 ms flashes at 20 Hz for 30 s 
and recorded optically evoked excitatory postsynaptic currents (EPSCs) in all MSNs from 
Thy1-ChR2-YFP mice, but not from wild-type (WT) mice (Figure 1D; n = 15 cells, n = 8 
mice). The evoked EPSCs were accompanied by the development of a slow inward current 
(at −75.6 mV after correcting for the tip potential) during the optical stimulation train 
(Figure 1D; see Figure S1 for expanded traces). This inward current peaked at −90 ± 19 pA, 
developed with a time constant (τ) of 1.1 ± 0.1 s, was maintained during the stimulation 
train, and decayed with a τ of 3.7 ± 0.2 s (Figure 1D; n = 15 cells, n = 4 mice). Furthermore, 
recordings from striatal astrocytes revealed a similar inward current of −281 ± 48 pA and 
with rise and decay τ values of 1.0 ± 0.1 and 4.3 ± 0.2 s, respectively (Figure 1E; n = 15 
cells, n = 8 mice). The finding that optically evoked inward currents could be measured in 
striatal MSNs and astrocytes, even though neither cell type expressed ChR2-YFP (Figures 
1A–1C), argues against photocurrents; the kinetics of the inward currents were also nearly 
three orders of magnitude slower than ChR2 activation and deactivation (Zhang et al., 2011). 
Additionally, the astrocyte responses argue against ionotropic glutamate receptor activation 
during corticostriatal axon stimulation (see later section) because such ion channels are 
unlikely to be expressed in striatal astrocytes (Chai et al., 2017). Moreover, the finding that 
the peak inward currents were larger in astrocytes than in MSNs suggests they may be due to 
elevation of K+. The astrocyte membrane has high resting K+ conductance and is thus 
sensitive to extracellular K+ increases.
We made K+ selective microelectrodes to directly measure K+ in the extracellular space of 
striatal slices before, during, and after optical stimulation in Thy1-ChR-YFP mice. The 
calibrated electrodes displayed the expected ~54 mV change for a 10-fold change in K+ 
(Figure 1F; mean of 4 electrodes shown). Furthermore, single 25 ms flashes at a range of 
powers (0–0.09 mW/mm2) elicited clear, transient extracellular K+ elevations in Thy1-
ChR2-YFP mice, but not in WT mice (Figure 1G; n = 14, n = 4 mice). Such transients 
peaked and decayed over seconds, as expected for release and subsequent washout of K+ in 
the extracellular space (Figure 1G). At power of 0.02 mW/mm2, 30 s trains of light flashes 
at 20 Hz elicited significant increases in extracellular K+ that were maintained for the 
duration of the stimulus, with rise and decay τ values of 2.1 ± 0.6 and 6.1 ± 0.5 s (Figure 
1H; Table 2). The kinetics of the K+ elevations were thus similar to the steady-state inward 
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currents recorded from MSNs and astrocytes (Figures 1D and 1E): the slightly slower time 
course measured with the electrodes may reflect sampling from the tip of the K+ electrode, 
whereas the MSN and astrocyte recordings sampled within the tissue. At peak, the 
extracellular K+ levels were elevated significantly to 7.2 ± 0.3 mM from a bath 
concentration of 4.5 mM (Figure 1H). Furthermore, the change in K+ evoked by a train of 
stimuli was not blocked by tetrodotoxin (TTX; 500 nM) or a combination of TTX, 
cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 μM), and D 2-Amino-5-
phosphonopentanoic acid (APV; 10 μM) to block APs and ionotropic glutamate receptors 
(Figure 1I; n = 14–23 slices, n = 4 mice). Similar, albeit as expected smaller, changes were 
measured when the flash duration was reduced to 2 ms (Figures S2A-S2D; n = 14–23 slices, 
n = 4 mice, 20 Hz). We also performed a set of experiments in the cortex to ascertain if the 
K+ elevations were a striatal specific effect. However, during optical stimulation, we 
measured slow-seconds time scale cortical pyramidal neuron depolarization (rise and decay 
0.3 ± 0.1 and 6.8 ± 0.7 s, respectively) and significant-seconds time scale elevations in 
extracellular K+ (8.7 ± 0.5 mM, with rise and decay 2.8 ± 0.2 and 9.1 ± 1.1 s, respectively) 
that were not blocked by TTX (Figures 1J and 1K; n = 16 slices, n = 4 mice). Responses 
were also observed with 2 ms flashes (Figures S2E and S2F; n = 12 slices, n = 4 mice).
Transient Extracellular K+ Elevations after AAV-Driven Expression of ChR2
Channelrhodopsin is frequently deployed using adeno-associated viruses (AAVs) for 
localized expression. We explored extracellular K+ changes following local expression of the 
commonly used ChR2 variant, ChR2(H134R), in the striatum. Intrastriatal hSynapsin1-
driven expression of ChR2(H134R)-YFP was robustly localized to NeuN positive neurons 
(Figures 2A and 2B), and optical stimulation with trains of increasing duration resulted in 
significant elevations of extracellular K+ to 8.8 ± 0.8 mM (Figure 2C; n = 16 slices, n = 4 
mice). The rise and decay τ values of these elevations were 3.2 ± 0.3 and 9.5 ± 1.4 s, 
respectively (Figures 2A–2C; n = 16 slices, n = 4 mice). Furthermore, the K+ elevations 
were not significantly affected by TTX (Figure 2D; p > 0.05, n = 11–12 slices, n = 4 mice), 
showing they were not due to AP firing. Next, we expressed ChR2(H134R)-mCherry in 
striatal astrocytes using AAV2/5 and the GfaABC1D promoter (Haustein et al., 2014; 
Shigetomi et al., 2013): as expected, we detected no colocalization with NeuN positive 
neurons but detected significant colocalization with S100β positive astrocytes (Figures 2E 
and 2F). Optical stimulation with trains of increasing duration resulted in significant 
elevation of extracellular K+ to 7.4 ± 0.2 mM (Figure 2G; n = 16 slices, n = 4 mice). The rise 
and decay τ values of such elevations were 3.0 ± 0.2 and 11.0 ± 1.4 s, respectively (Figures 
2E–2G; n = 16 slices, n = 4 mice). Responses were also observed with 2 ms flashes (Figures 
S2G and S2H; n = 16 slices, n = 4 mice). Astrocytes are proposed to regulate extracellular K
+
 dynamics via Ba2+ sensitive Kir4.1 ion channels (Nwaobi et al., 2016). Ba2+ block (100 
μM) of Kir4.1 did not significantly alter the peak change in K+ evoked by ChR2(H134R) 
activation; however, suggesting a possible role for Kir4.1 in K+ clearance, Ba2+ significantly 
increased the rise and decay times of the extracellular K+ elevations (Figure 2H; n = 16 
slices, n = 4 mice). To explore the possibility that the ChR2-mediated extracellular K+ 
elevations may be due to brain slicing, we repeated the experiments following expression of 
ChR2(H134R) in cortical astrocytes in vivo (Figure 2I). We measured significant, albeit 
smaller, slow K+ elevations in the cortex in vivo of awake head-fixed mice (rise and decay 
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times of 0.5 ± 0.4 and 1.4 ± 0.7 s, respectively), but not in mice that received a control AAV 
(Figure 2J; n = 4 mice each). Finally, we compared the K+ elevations measured at room 
temperature and at more physiological temperatures (34°C): we found significant elevations 
at both temperatures and only subtle effects of temperature on the kinetics of extracellular K
+
 (Table 1; Figure S4).
ChR2-Mediated Extracellular K+ Elevations Increased MSN Excitability in Brain Slices
The finding that ChR2(H134R) activation in astrocytes caused an increase in extracellular K
+
 (~7.4 mM) comparable to that caused by neuronal ChR2 activation (~8.8 mM; Figures 2C 
and 2G) provided an opportunity to evaluate if such K+ fluxes were consequential for 
neuronal function. To this end, we expressed ChR2(H134R)-mCherry in adult striatal 
astrocytes using AAV2/5 and the GfaABC1D promoter (Haustein et al., 2014; Shigetomi et 
al., 2013). We confirmed in these specific experiments that ChR2(H134R)-mCherry was 
expressed in ~80% of striatal S100β positive astrocytes, but not in striatal NeuN positive 
neurons (Figures 3A and 3B; n = 12 sections, n = 4 mice). In this experimental approach, we 
identified and recorded from MSNs but optically stimulated ChR2(H134R)-mCherry 
expressing astrocytes nearby in the dorsolateral striatum. A single brief train of ten 2 ms 
flashes significantly and slowly depolarized MSNs by ~2 mV (Figure 3D; n = 14 MSNs, n = 
4 mice). A longer 30 s train of flashes depolarized MSNs by ~7 mV for the duration of the 
stimulation train (Figure 3D; n = 14 MSNs, n = 4 mice). The depolarization also peaked and 
decayed with seconds time scale kinetics similar to those observed for extracellular K+ 
elevations (Figures 2G and 3D). Some past studies have suggested that ChR2 stimulation of 
astrocytes evokes astrocyte glutamate release, which is proposed to be a gliotransmitter 
acting on neurons. However, we detected no change in excitatory postsynaptic potentials 
(EPSPs) arriving onto MSNs during optical stimulation of astrocytes, and of most relevance 
here, the change in MSN membrane potential was not affected by the bath application of 
CNQX and APV (10 μM), which completely blocked all EPSPs (Figure 3D). These data 
suggest that ChR2- mediated stimulation of striatal astrocytes depolarized MSNs 
significantly, likely by K+ elevations and not via glutamate release (Chai et al., 2017; see 
also Nedergaard and Verkhratsky, 2012 and Sloan and Barres, 2014). To explore neuronal 
consequences more carefully in the striatum, we applied slow ramps to determine the 
amount of current required to trigger APs in MSNs (rheobase) before, during, and after 
optical stimulation of ChR2-expressing astrocytes (Figure 3E). In all cases, we measured 
significant MSN membrane potential depolarization and a significant drop in the rheobase 
(Figure 3E; n = 14 MSNs, n = 4 mice). Furthermore, following in vivo stimulation of 
astrocytes expressing ChR2(H134R), we detected a significant increase in the expression of 
the immediate early gene, cFos, in 20% of DAPI-positive cells in the striatum (Figures 3F–
3H; n = 7 slices, n = 3 mice), which was significantly greater than that observed in mice 
expressing tdTomato in astrocytes (Figures 3G and 3H). Of the cells with elevated cFos 
expression following in vivo astrocyte optogenetic stimulation, ~35% were S100β positive 
astrocytes (Figures 3F and 3H), whereas ~18% were NeuN positive neurons (Figures 3G and 
3H). These data are consistent with the interpretation that optogenetic excitation of 
ChR2(H134R)-expressing astrocytes in vivo was sufficient to alter astrocyte and neuronal 
excitability, resulting in significantly elevated cFos expression in a proportion of the cells. 
During our experiments, we observed no overt change in open-field activity or general 
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behavior during optical stimulation of ChR2(H134R)-expressing astrocytes relative to 
control mice (Figure S3).
Computational Modeling: MSN Excitability Increase Recapitulated by K+ Elevation Alone
We adapted a MSN model (Mahon et al., 2000) (Figure 4A; Table 2), which comprised a 
single compartment representing a MSN soma and proximal dendrites, and eight active 
Hodgkin-Huxley (HH)-based models of variable membrane conductances. The modeled 
currents are persistent sodium (INap); slowly inactivating sodium (INas); transient sodium 
(INat); delayed rectifier potassium (IKDR); inwardly rectifying potassium (IKIR); persistent 
potassium (IKRP); fast inactivating A-type potassium (IKAf); slow inactivating A-type 
potassium (IKAs); and a lumped, non-specific ion leak current. We replaced the non-specific 
leak current with three Goldman-Hodgkin-Katz (GHK)-based specific ion leaks (Cl−, Na+, 
and K+). We used the model to explore how K+ concentration changes measured in the 
experiments reported in Figure 3 affect MSN excitability in silico. We adjusted the model’s 
parameters to replicate basal MSN spiking features (Mahon et al., 2000) (see STAR 
Methods). We then varied conductance and permeability parameters to constrain a 
population of MSN models to reproduce the observed ranges of resting membrane potential 
values and resting levels of excitability during light off and light on conditions. We required 
that each model reproduce these measures at both 4.5 and 7.5 mM extracellular K+ to be 
included in the population. By asking if models exist sensitive to K+ changes within 
experimentally observed ranges from Figures 1 and 2, we aimed to test if the modeled range 
of extracellular K+ was sufficient to explain the data. Current injection ramp protocols were 
replicated for each model instance using two extracellular K+ concentration parameters 
related to Figure 3 (i.e., 4.5 and 7.5 mM). A model instance comprised a unique set of ionic 
conductances and specific leak permeability parameters. Using a modified version of the 
parameter optimization via evolutionary algorithms approach (Rumbell et al., 2016) (see 
STAR Methods), we identified a population of model instances that reproduced the range of 
excitability features measured before and after optical stimulation of astrocytes expressing 
ChR2 (Figure 3) when the extracellular K+ increased from 4.5 to 7.5 mM K+ (Figure 4B), 
respectively. The resulting population of model instances recapitulates a range of excitability 
features measured empirically, which are modulated consistently in the same direction by 
extracellular K+ across all model instances, thus establishing extracellular K+ as an 
independent parametric change in the model sufficient to explain changes in MSN 
excitability observed during ChR2 excitation (Figure 4). We further optimized these models, 
constraining with specific spiking features from one of the experimental traces. One such 
outcome generated the waveforms depicted in Figure 4C, which closely recalls experimental 
data of Figure 3. To explore the full range of extracellular K+ concentrations, we 
incrementally varied K+ in the model used to generate Figure 4C. Increases in extracellular 
K+ depolarized MSNs and decreased rheobase in the model (Figure 4D). K+ above 9 mM 
caused seizure-like bursting activity in the MSN model; to generate plots in Figure 4D, we 
thus did not exceed 7.5 mM K+. Overall, this MSN model supports the hypothesis that 
extracellular K+ elevations are sufficient per se to reproduce the increased excitability 
changes measured during experiments in Figure 3 without the need to invoke additional 
factors.
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ChR2-Mediated Extracellular K+ Elevations Increased MSN Excitability In Vivo
Experiments reported in the preceding sections show that optical stimulation of ChR2-
expressing astrocytes causes extracellular K+ increases (Figure 2) and MSN depolarization 
(Figure 3D), as well as increased MSN excitability in brain slices (Figure 3E) and in silico 
(Figure 4). In order to determine whether such responses translated into increased MSN AP 
firing in vivo, we recorded MSN activity in awake behaving mice (Figure 5) using multisite 
silicon probes (Bakhurin et al., 2016). ChR2 was selectively expressed in striatal astrocytes 
using approaches described in the preceding sections. Silicon probes with an inbuilt light-
emitting diode (LED) were used for optical excitation and electrophysiological recording 
(Figure 5A) in awake behaving mice on a spherical treadmill. MSN APs were analyzed 
offline, sorted using established criteria (Bakhurin et al., 2016) and AP frequency assessed 
before, during, and after optical stimulation (Figure 5A). Post hoc, we verified in each 
mouse that AAV-driven ChR2 expression was overlapping anatomically with the site at 
which the silicon probes were placed for electrophysiological assessments (Figure 5B). As a 
control group, we used mice in which tdTomato was identically expressed in astrocytes: 
MSN APs from tdTomato and ChR2 groups were identified and recorded (Figure 5C). 
Figure 5D shows AP firing of 60—70 MSNs before, during, and after optical stimulation for 
the control tdTomato and the ChR2 groups. From the raster plots, it was clear that optical 
stimulation did not evoke alterations in MSN AP firing in the control group, but optical 
stimulation evoked clear increases in AP firing in the ChR2 group (Figure 5D; n = 5 mice in 
each group). These data are summarized as average firing over time (Figure 5E) or as 
histograms before, during, and after optical stimulation (Figure 5F). Together with the 
studies of extracellular K+ increases, MSN excitability, and computational modeling, these 
in vivo recordings strongly indicate that optical stimulation of ChR2-expressing astrocytes 
can cause significantly elevated MSN firing. Our brain slice data and modeling suggest that 
astrocyte ChR2-mediated K+ elevations are the underlying cause.
DISCUSSION
We show that transient extracellular K+ elevations accompany optogenetic excitation with 
two widely used variants of ChR2 (wild-type and H134R) in a common transgenic mouse 
model, following AAV-mediated delivery in brain slices and in vivo, regardless of whether 
the ChR2 is expressed in neurons or astrocytes. The simplest interpretation is that K+ flows 
down its electrochemical gradient through the ChR2 pore from the inside to the outside of 
cells. The ChR2 pore displays a K+ to Na+ relative permeability of ~0.4 (Lin et al., 2009; 
Nagel et al., 2003) and a minimal open pore diameter of ~6.2 Å (Richards and Dempski, 
2012). Thus, opening of the ChR2 pore carries inward Na+ current and outward K+ current 
under physiological conditions as determined by the respective ion equilibrium potentials 
relative to the cell’s membrane potential. Our data show that this outward K+ flux is 
significant and elevates K+ concentrations in the extracellular space to consequential levels 
during seconds-long optical stimulations usually employed in astrocyte studies.
Interestingly, our observations recall work at the neuromuscular junction where a slow 
endplate potential due to K+ release directly by nerve terminal APs was detected (Katz and 
Miledi, 1982). Several other papers have similarly documented K+ elevations during 
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neuronal activity (Heinemann et al., 1990; McCreery and Agnew, 1983; Walton and Chesler, 
1988). However, the K+ elevations we report are not due to K+ release during the AP 
because they occurred when APs were blocked and when ChR2 was expressed in astrocytes 
devoid of APs. Furthermore, although K+ is expected to flow through open endogenously 
expressed voltage-dependent K+ channels that open during ChR2-mediated depolarization, 
this cannot account for our observations: astrocytes have little if any rectification indicative 
of voltage-gated K+ conductance, and owing to their low membrane resistance and high 
resting ohmic K+ conductance, they rarely deviate from near the K+ equilibrium potential. In 
light of these considerations, we discuss the relevance of ChR2-mediated K+ fluxes in 
relation to the diverse uses of optogenetic excitation strategies, but with a focus on astrocyte 
studies.
A logical interpretation of our astrocyte studies is that optogenetic stimulation increased 
neuronal excitability via extracellular K+ elevations, which was recapitulated in a 
computational model. Our studies should not be overinterpreted, however, as indicating that 
we dismiss gliotransmission (Araque et al., 2014), but our studies highlight an important 
consideration with the use of ChR2 in these regards. It will be important to candidly 
consider if cellular and behavioral responses ascribed to ChR2-evoked gliotransmission onto 
neurons (reviewed by Bang et al., 2016) could instead reflect elevations of extracellular K+. 
Even subtle changes in K+ will change neuronal excitability directly (Hille, 2001) and 
indirectly by reducing glutamate clearance by electrogenic transporters (Barbour et al., 
1988; Szatkowski et al., 1990). This will lead to elevated ambient glutamate levels, which 
could conceivably be interpreted as glutamate gliotransmission. If so, the relevance of this 
phenomenon to circuits and behaviors may have been misinterpreted. Furthermore, strong 
excitation of astrocytes with ChR2 may change extracellular electric fields, which may 
affect neuronal ephaptic signaling (Jefferys, 1995). The use of optogenetic excitation 
approaches to study astrocytes, therefore, requires careful consideration not least because 
these cells are largely electrically silent (Kuffler, 1967). It is not immediately clear why 
artificially changing membrane potential is appropriate to explore astrocyte physiology, 
although such approaches are obviously meaningful for neurons.
Our goals in this study were not to identify a past behavioral study based on ChR2 and 
highlight it as being better explained by transient K+ elevations. Instead, we followed 
empirical observations that show K+ elevations occur, and we suggest this should be 
considered in the interpretation of future studies using ChR2, especially in astrocytes. We 
also did not perform detailed behavior analysis, but during our experiments, we observed no 
overt change in open-field activity or general behavior during optical stimulation of 
ChR2(H134R)-expressing striatal astrocytes relative to control mice. This is unsurprising 
because astrocytes do not have axonal projections and do not discriminate between D1 and 
D2 MSNs. Thus, we suggest that the elevation of K+ would not discriminate between D1 
and D2 MSNs, both of which exist within single astrocyte territories (Chai et al., 2017; 
Octeau et al., 2018a) and may drive compensatory signals in relation to simple behaviors. 
Instead, we interpret the in vivo data to show that elevated cFos responses most likely reflect 
neuronal firing caused by transient K+ elevations, a finding confirmed by recording neuronal 
activity in vivo.
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It is problematic to search for a specific striatal microcircuit-related behavior that may be 
caused by astrocyte-mediated K+ increases because unlike a neurotransmitter, K+ will affect 
the functions of all cells, not just neurons. Instead, we explored the effect of astrocyte ChR2-
mediated K+ elevations on the behavior of single neurons using modeling and experiments. 
These data strongly suggest that ChR2-mediated optical excitation of astrocytes can affect 
the excitability of neurons via K+ elevations. Since K+ is tightly regulated, even small 
changes are expected to affect neurons, astrocytes, microglia, and blood vessels 
(McDonough and Youn, 2017). For example, K+ is potently ictogenic at around 9 mM (de 
Curtis et al., 2018), has vasoconstrictor and vasodilator actions on brain vasculature 
(Girouard et al., 2010), contributes to neurological disease phenotypes (Nwaobi et al., 2016; 
Tong et al., 2014), and will synchronize neuronal activity (Jefferys, 1995). Subtle changes in 
K+ will depolarize neurons and alter the open and closed probabilities of the activation and 
inactivation gates of voltage-gated K+ and Na+ channels, which of course will alter AP 
properties through Hodgkin-Huxley outcomes (Hodgkin and Huxley, 1952). Such effects 
may explain why ChR2-mediated stimulation of astrocytes silenced neurons in the 
subthalamic nucleus in pioneering early studies (Gradinaru et al., 2009). Hence, long-term 
optogenetic stimulation in vivo may cause complex effects on cells in parallel with the 
effects desired by expression of ChR2 in specific cell types. K+ changes may also engage 
local circuits that modulate behavior through ionic or ephaptic mechanisms (Jefferys, 1995) 
in addition to the pathways targeted by ChR2 expression. These are relevant considerations 
with the use of optogenetic strategies in vivo and may predict the emergence of unrelated, 
possibly pathogenic, effects during use. Additional consequences of the larger and more 
compartmentalized intracellular Na+ fluxes also merit consideration. Perhaps, infrared 
induced electro-mechanical effects (Plaksin et al., 2018) may provide opportunities for 
remote neuronal excitation (Shapiro et al., 2012) without reliance on substantial ionic 
currents. In the case of astrocytes, new tools are clearly needed to remotely manipulate 
physiological levels of activity.
It would be egregiously misleading of us to suggest that transient K+ elevations markedly 
contribute to most optogenetic excitation studies. This is not our intention. More 
parsimoniously, we suggest that the impact of extracellular K+ dynamics will depend on the 
membrane properties of the neurons in question (e.g., their input resistance, levels of open K
+
 channels, and rectification), as well as the activation and inactivation thresholds for 
voltage-gated ion channels. Local neuroanatomy will also be relevant, as this will determine 
how K+ elevations are dissipated in the extracellular milieu and will affect local electric 
fields. Overall, our insights echo caution by others emphasizing effects of light itself 
(Rungta et al., 2017) and the importance of depolarization block (Herman et al., 2014) and 
of circuit-related off-target effects in the case of silencing approaches (Otchy et al., 2015; 
Südhof, 2015). Admittedly, our work may have little relevance to the use of ChR2 in 
neuronal studies where optical stimuli are usually brief, but we suggest transient K+ 
increases are likely to be markedly consequential in astrocyte and behavioral studies when 
optical stimuli are typically prolonged. The impact of such changes may have been missed 
when independent electrophysiological evaluations were not employed to measure cellular 
level electrical changes and extracellular K+ levels. We suggest that cellular 
neurophysiology is necessary in parallel with in vivo studies in order to make adequate 
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interpretation of neural circuit and behavioral outcomes in studies employing ChR2 and 
other related optogenetic strategies.
STAR★METHODS
CONTACT FOR REAGENT AND RESOURCE SHARING
Requests for resources and reagents should be directed to and will be fulfilled by the Lead 
Contact, Baljit S. Khakh (bkhakh@mednet.ucla.edu). Adeno-associated viruses and 
plasmids are, or will, be made available on Addgene or through the University of 
Pennsylvania Vector Core.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All animal experiments were conducted in accordance with the National Institute of Health 
Guide for the Care and Use of Laboratory Animals and were approved by the Chancellor’s 
Animal Research Committee at the University of California Los Angeles. Mice were housed 
with food and water available ad libitum in a 12-hour light/dark environment. Mice were 
healthy with no abnormal behavioral phenotypes and were not involved in prior studies. For 
all experiments, mice were sacrificed during the light cycle. Both male and female mice 
were used for experiments (between 8–16 weeks of age).
METHODS DETAILS
Mouse lines—Most experiments were conducted on C57BL/6N mice (from Taconic) from 
an in-house colony. Heterozygous Thy1-ChR2-YFP mice were obtained from Jackson 
Laboratories (strain B6.Cg-Tg(Thy1-COP4/EYFP)9Gfng/J; stock #007615) and have been 
published by others (Arenkiel et al., 2007). Thy1-ChR2 mice were maintained as 
heterozygous × wt breeding pairs in an in-house colony. For all experiments, wt mice were 
C57BL/6N.
Plasmid and adeno-associated viruses (AAV)—All plasmid constructs were 
generated using standard molecular biology techniques and the In-Fusion HD Cloning Kit 
(Clontech). All constructs were sequenced before AAV generation. For all constructs, we 
modified plasmid pZac2.1 GfaABC1D Lck-GCaMP6f (Addgene plasmid # 52924). Briefly, 
we generated adeno-associated virus plasmids (AAV2/5) capable of expressing the selected 
cDNA using the following strategy. For the plasmid, GfaABC1D-ChR2(H134R)-mCherry, 
we removed Lck-GCaMP6f using Xho1 and Xba1 restriction enzymes and infused the 
ChR2-(H134R)-mCherry cDNA. The fully sequenced “pZac2.1” plasmids were sent to the 
Penn Vector Core, which used them to generate AAV serotype 2/5 for this construct yielding 
a concentration of ~1 × 1013 genome copies/ml (gc/ml). This construct has been deposited at 
Addgene in the Khakh lab repository, and the AAVs are available from the UPenn Vector 
Core Catalog.
In vivo microinjections of AAVs—Male and female P42-P56 C57BL/6N mice were 
used in all AAV experiments. Briefly, animals were deeply anesthetized using isoflurane 
(induction at 5%, maintenance at 1%−2.5% v/v). After induction of anesthesia, the mouse’s 
head was carefully placed into a stereotaxic frame and gently secured by blunt ear bars and 
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their nose was placed into an anesthesia system (David Kopf Instruments). Before the 
surgery, mice were administered 0.05 mL of buprenorphine (Buprenex, 0.1 mg/ml) 
subcutaneously. 10% povidone iodine and 70% ethanol were used to sterilize the incision 
site. Short (5–8 mm) skin incisions were made, followed by craniotomies ~2 mm in diameter 
using a small steel burr (Fine Science Tools) powered by a highspeed drill (K.1070; 
Foredom) directly above the site of the injection. Sterile saline was applied onto the skull to 
lessen heating caused by drilling. Viral injections were performed using a stereotaxic 
apparatus (David Kopf Instruments) which guided the placement of angled bevel glass 
pipettes (1B100 – 4; World Precision Instruments) into the appropriate brain region. Our 
stereotaxic coordinates (Axes: Anterior-Posterior / Medial-Lateral / Dorsal-Central; relative 
to Bregma) for AAV microinjection were as follows: dorsolateral striatum: +0.8 / +2.0 / −2.4 
and superficial motor cortex: −0.1 /+0.7 / −0.1. In this study, the following viruses and their 
titers were used: AAV2/5 GfaABC1D-ChR2(H134R)-mCherry (8.1 × 1012 gc/ml), AAV2/5 
hSynapsin1-ChR2(H134R)-YFP (2.9 × 1012 gc/ml, Lot# AV4319J, UNC GTC Vector Core). 
AAVs were injected by using a syringe pump at 200 nl/min (Pump11 PicoPlus Elite; 
Harvard Apparatus). The glass needles were left in place for at least 6 min and slowly 
removed over the course of 1 minute. The incisions were closed with single external 6 – 0 
nylon sutures. After surgery, animals recovered overnight in cages which were placed 
halfway on a low-voltage heating pad. As an analgesic, subcutaneous buprenorphine was 
given twice daily for 48 hours following surgery. In addition, trimethoprim/sulfadiazine diet 
(275 & 1,365 ppm, TD.06596, Teklad) was fed ad lib prophylactically for one week after 
surgery. Following AAV injection and recovery, the mice were sacrificed 22–28 days later 
for all experiments.
Acute brain slice preparation and single cell recordings—Acute brain slices were 
prepared from P42–70 wt, Thy1-ChR2 mice or AAV microinjected mice. Briefly, animals 
were deeply anesthetized and decapitated. The brains were placed in ice-cold modified 
artificial CSF (aCSF, containing in mM: 194 sucrose, 30 NaCl, 4.5 KCl, 1 MgCl2, 26 
NaHCO3, 1.2 NaH2PO4, and 10 D-glucose) and cut into 300 μm-thick coronal or 
parasagittal slices containing areas of the striatum and cortex. Brain slices equilibrated for 
~30 min at 32–34°C in normal aCSF (containing in mM; 124 NaCl, 4.5 KCl, 2 CaCl2, 1 
MgCl2, 26 NaHCO3, 1.2 NaH2PO4, and 10 D-glucose) which was continuously bubbled 
with a mixture of 95% O2/5% CO2, stored at room temperature in the same buffer. All slices 
were used for experiments within ~6 hr of animal death. Cells were visualized using IR-DIC 
optics on an upright microscope (BX61WI, Olympus). pCLAMP10 software and a 
MultiClamp 700B amplifier and Digidata 1322A was used for electrophysiology (Axon 
Instruments). For all recordings we used normal aCSF at 20–25°C. For patch recordings, the 
intracellular solution contained the following (in mM): 135 potassium gluconate, 3 KCl, 0.1 
CaCl2, 10 HEPES, 1 EGTA, 8 Na2-phosphocreatine, 4 Mg-ATP, 0.3 Na2-GTP, pH 7.3 
adjusted with KOH. The initial access resistances were < 20 MΩ for all cells; if this changed 
by > 20% the cell was discarded.
Recording K+ ion dynamics in slices and in vivo—To record slice K+ dynamics, we 
made K+ selective microelectrodes (Octeau et al., 2018b). Briefly, borosilicate glass 
capillaries were pulled to a fine tip of ~2–5 μm and then baked at ~200°C in the presence of 
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5% dichlorodimethylsilane for 1 hour up to overnight to enhance the hydrophobicity of the 
glass by silanization. The silanized capillaries were then allowed to cool to room 
temperature and then broken to a diameter of approximately 15 μm using a blunt instrument. 
The capillaries were then backfilled with a solution containing 300 mM NaCl and 10mM 
HEPES, pH 7.4. The microelectrode tip was then immersed in a small volume (~1 μl) of 
potassium ionophore cocktail (5% w/v valinomycin, 93% v/v 1,2-dimethyl-3-nitrobenzene, 
2% w/v potassium tetrakis(4-chlorophenyl)borate) and this solution was drawn 
approximately 1 mm into the tip by capillary action. The primed microelectrode was then 
fixed into an electrode holder on the connected to an amplifier and digitizer which 
transmitted voltage responses to a PC recording the responses in pCLAMP10. The voltage 
responsiveness of all microelectrodes were calibrated with solutions of aCSF which had 
various concentrations (in mM 0.1, 1.0, 10 and 100) of KCl, for these solutions iso-osmolar 
quantities of NaCl were subtracted to maintain total solution osmolarity at ~310 mOsm. The 
K+-selective microelectrodes were then slowly inserted into prepared brain slices which 
were superfused with 4.5 mM K+ aCSF and the voltage responses to blue LED flashes were 
measured. For in vivo measurement of K+ ion dynamics mice were prepared with a cranial 
bar fixed to the skull to maintain brain position. Mice were anesthetized with isoflurane (3%
−5% induction, 1.5% maintenance) ten minutes after injection of a systemic analgesic 
(carprofen, 5 mg per kg of body weight) and placed in a stereotaxic frame. During surgery, 
mice were always kept at 37°C using a feedback-controlled heating pad. Pressure points and 
incision sites were injected with lidocaine (2%), and eyes were protected from desiccation 
using artificial tear ointment. The skin above the skull was cut and a custom-made 
lightweight metal head holder was implanted on the skull using Vetbond (3M) and a 
recording chamber was built using dental cement (Ortho-Jet, Lang). Access to the brain was 
closed using a thin layer (~2 mm) fast drying silicone elastomer (Kwik-sil, WPI) and a top 
layer of dental cement. Mice had a recovery period from surgery of five days, during which 
they were administered amoxicillin (0.25 mg per ml in drinking water through the water 
supply). After the recovery period, mice were habituated to head fixation on the spherical 
treadmill. 20–25 days following viral injection mice were placed onto the spherical treadmill 
and maintained in a head fixed position using a metal arm to grip the head holder attached to 
the mouse’s skull. Following head restriction, the dental cement and silicone covering was 
removed and ACSF was applied to the surface of the brain to prevent tissue drying. To 
assess potassium ion changes a K+ selective microelectrode was prepared, calibrated and 
then lowered ~50 microns perpendicularly into the cortical surface. Electrode potentials 
were allowed to stabilize over the course of 8–10 minutes before recording. Light flashes 
from a LED-Blue optogenetics light source were delivered via a fiber which was controlled 
remotely using a TTL pulse from Pulser software version 2.3.1 (Prizmatix, Israel). Electrode 
responses were captured and recorded using an Axopatch 700B amplifier connected via a 
digitizer to a computer with pCLAMP9 software. After completion of the experiments, the 
mice were euthanized by pentobarbital injection and immunostaining was performed on the 
brains to confirm viral expression.
In vivo ChR2 activation and behavioral assessment—To deliver blue light to the 
striatum we constructed a fiber optic cannula using a DIY-cannula kit (Prizmatix). The fiber 
optic was cleaved into the desired length, which was approximately 10 mm. A small, ~1 μL 
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droplet of epoxy resin was applied to the flat opening of a 6.5 mm long cannula. The fiber 
was then inserted through the epoxy bead into the cannula until it protruded approximately 1 
mm from the opposite end of the cannula. Using a heat gun, we then cured the epoxy resin 
and secured the fiber in place. When the epoxy cooled, the fiber on the convex end of 
cannula was made transparent using polishing paper of increasing grits; from 4500 to 60000 
final grit strength. Cannulated fibers were tested for their integrity and maximum light 
output (≥8 mW) before being used for the implantation. To implant the cannulated fiber 
optic, mice were first anesthetized with isoflurane (induction at 5%, maintenance at 1%
−3%). The scalp was shaved and animals were gently fitted into a stereotaxic frame with 
their heads secured by ear bars. Ophthalmic ointment was applied to eyes to prevent dryness 
and postoperative discomfort. The surgical area was sterilized thrice with 10% povidone 
iodine and 70% isopropanol. A skin incision was made on top of the head and the 
periosteum was removed by swiping with a cotton swap wetted with 3% hydrogen peroxide. 
A mark was made on the skull at coordinates above the dorsolateral striatum using the 
stereotactic apparatus. At this mark, a small opening (~1 mm in diameter) was drilled using 
small steel burr powered by high speed drill; during which saline was applied to the skull to 
diffuse heating and remove bone debris. Afterward, 1 μL of AAV was injected at 200 nl/min 
(dorsolateral striatum coordinates relative to bregma: in mm +0.8/+1.8/−2.4). The needle 
was kept in place for 10 minutes and slowly removed over a 5 minute period. Subsequently, 
the cannulated fiber optic was slowly lowered into the striatum and secured in place using 
Vetbond tissue adhesive (3M Maplewood, MN) and dental cement. Three weeks after the 
surgery the mouse was connected to optical stimulation system (Prizmatix). The optical 
cannula was connected to the patch cord through the mating sleeve (Prizmatix). Blue light 
pulses were applied in a stimulation paradigm consisting of 10 s light on and 10 s light off 
for a period of 60 min. During this period the mouse behavior in an opaque open chamber (L 
× W × H in cm: 29 × 29 × 15) was recorded using a camera placed above the field. 
Locomotion was tracked by ANY-maze software (Stoelting Co.) and the tracking accuracy 
was verified by the investigator.
Immunohistochemistry (IHC)—Prior to transcardial perfusion, mice were euthanized 
with 200 mg/kg pentobarbitol (i.p.). Once reflexes were lost, the abdominal cavity was 
opened and heparin (0.1 ml, 100 USP) was injected into the heart to avert blood clotting. 
Mice were perfused with ~50 mL of 0.1 M phosphate buffered saline (PBS) followed by ~50 
mL 10% buffered formalin (Fisher Scientific). After careful removal from the skull, the 
brain was post fixed in 10% buffered formalin overnight. The tissue was cryoprotected (0.1 
M phosphate buffered saline with 30% sucrose) the following day for at least 2 days at 4°C 
until use. 40 μm sections were sectioned using a cryostat (Leica) and processed for 
immunohistochemistry. Sections were washed 4 times in 0.1 M PBS for 5 min each, and 
then incubated in a blocking solution comprising 5% NGS in 0.1 M PBS with 0.2% Triton 
X-100 for 1 hr at room temperature with gentle rocking. Sections were then incubated in 
primary antibodies diluted in ‘blocking solution overnight at 4°C. The following primary 
antibodies were used: chicken anti-GFP (1:1000; Abcam Cat# ab13970 RRID:AB_300798), 
rabbit anti-NeuN (1:1000; Cell Signaling; RRID: AB_2630395), rabbit anti S100β (1:2000, 
Abcam Cat# ab41548 RRID:AB_956280), guinea pig anti-cFOS (1:500, Synaptic systems 
#226004 RRID:AB_2619946), rabbit anti-dsRed (1:1000, Clontech Laboratories Cat# 
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632496 RRID:AB_10013483), mouse anti-mCherry (1:1000, St. John’s Cat# STJ97087), 
guinea pig anti-NeuN (1:500; Synaptic Systems Cat # 266 004; RRID:AB_2619988), mouse 
anti-neurofilament (1:250, BioLegend Cat# SMI-312R, RRID:AB_2314906). The next day 
the sections were washed 4 times in 0.1 M PBS for 5 min each before incubation at room 
temperature for 1–2 hr with secondary antibodies diluted in 0.1 M PBS with 5% NGS and 
0.2% Triton X-100. The following Alexa conjugated secondary antibodies were used: goat 
anti-guinea pig 488 (1:1000, Molecular Probes Cat# A-11073 RRID:AB_142018), goat anti-
rabbit 546 (1:1000, Molecular Probes Cat# A-11035 RRID:AB_143051), goat anti-chicken 
488 (1:1000, Molecular Probes Cat# A-11039 RRID:AB_142924), goat anti-guinea pig 546 
(1:1000, Thermo Fisher Scientific Cat# A-11074 RRID:AB_2534118) and goat anti-mouse 
546 (1:1000, Molecular Probes Cat# A-11030 RRID:AB_144695). The sections were then 
rinsed 4 times in 0.1 M PBS for 5 min each, and briefly dipped in distilled water before 
being dried, mounted and coverslipped on microscope slides. Fluorescence images were 
taken using UPlanSApo 20X 0.85 NA and UPlanFL 40X 1.30 NA oil immersion objective 
lens and FV1000 Fluoview confocal laser-scanning microscope. We used the 488 nm 
emission wavelength of an Argon laser to excite Alexa488, with the intensity adjusted to 
0.5%−10% of the maximum output, which was 10 mW. The sample emission light path 
consisted of a band-pass emission filter (505–525 nm) before the photomultiplier tube. 
Alexa 546 was excited by the 543 nm wavelength of a Helium-neon laser at 2%−30% of the 
maximum output (1 mW). The emitted light pathway consisted of a dichroic mirror 
(SDM560) and a 560–600 nm band-pass filter. For imaging Alexa 647, we used a 635 nm 
light emitting diode (LD635, Olympus) at 0.1%−15% of its power output which was 23 mW. 
The emitted light pathway consisted of a dichroic mirror (SDM640) and a 655–755 band-
pass filter. For fluorescence images of brain hemisections, individual images were acquired 
using identical settings and stitched together to show a single composite image of the tissue 
section.
Computational model of MSNs—The computational model of the medium spiny 
neuron (MSN) was refined from a past study (Mahon et al., 2000), but is reported in full 
here. The model comprises a single compartment, representing a MSN soma and proximal 
dendrites, and eight active Hodgkin-Huxley (HH) based models of variable membrane 
conductances associated with MSN ion channel currents. The eight modeled currents are the 
persistent sodium current (INap), the slowly inactivating sodium current (INas), the transient 
sodium current (INat) the delayed rectifier potassium current (IKDR), the inward rectifying 
potassium current (IKIR), the persistent potassium current (IKRP), the fast inactivating A-
current (IKAf), the slow inactivating A-current (IKAs), and a lumped, non-specific ion leak 
current.
The model is computationally inexpensive compared to multicompartment models (Wolf et 
al., 2005), and in its original form captured MSN spike timing dynamics such as 
characteristic latency to first spike and short-term facilitation of intrinsic excitability. A 
major drawback of the original model is its assumption of different reversal potentials (EK or 
ENa) among ion channels selective for the same ion species, rendering it biophysically 
unrealistic, because these channels likely share the same intracellular and extracellular ion 
concentrations. To resolve this discrepancy, we replaced the model’s non-specific leak 
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current with specific leak currents for potassium, sodium and chloride, each based on the 
Goldman-Hodgkin-Katz (GHK) equation:
Φs = Pszs
2VmF
2
RT
Si − So exp −zsVmF /RT
1 − exp −zsVmF /RT
,
where ϕs is the current density (flux) (amperes per unit area) of ion S, Ps is the permeability 
of ion S (μm/ms), [S]i is the intracellular concentration of ion S (mM), [S]o is the 
extracellular concentration of ion S (mM), and Vm is the membrane potential (mV). Reversal 
potentials for each ion species are then calculated once for all currents using the Nernst 
equation:
Es =
RT
ZF ln
So
Si
,
where R is the universal gas constant 8.314 J⋅K−1⋅mol−1, T is the temperature 295.15 K, z is 
the valence of the ionic species, and F is the Faraday’s constant 96,485 C⋅mol-1. We set 
external and internal ion concentrations to those used for the experiments reported in 
preceding sections. The calculation of MSN membrane potential in our revised model then 
follows:
CdVdt = INaT + IKDR + IKIR + IKRP + IKA f + IKAs + INaS + INaP + ICl, leak + INa, leak + IK, leak
+ IIn j,
where V is the membrane potential. Ion channel currents followed I = gmkh(V − E), where 
each g is the conductance of an ion channel current (noted by subscript). IInj is an injected 
current. IX is either the specific leak current for each ion species or the ion channel current. 
Specific leak current is derived by multiplying current density (Φs) from Equation 1 by the 
compartment surface area (assumed to be 1 μm2). Ion channel currents are derived by 
multiplying channel conductance (gX) by membrane potential minus the ion specific reversal 
potential (V − EX) by compartment surface area. The activation m and optional inactivation 
h gating variables were as reported in Mahon et al. (2000) followed:
dp
dt = αp(1 − p) − βpp,
where p represents (m, h, n). For channel Nat and KDR, the gating parameters were as 
follows:
αm = − 0.1(V + 28)/exp(( − 0.1(V + 28)) − 1)
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βm = 4.0exp( − (V + 53)/18)
αh = 0.07exp( − (V + 51)/20)
βh = 1/(exp( − 0.1(V + 21) + 1)
αn = − 0.01(V + 27)/exp(( − 0.1(V + 27)) − 1)
βn = 0.125exp( − (V + 37)/80)
All other currents obeyed the Boltzmann equation for steady state activation
s∞(V) = 1/ 1 + exp − V − Vs /ks
and the voltage dependent time constants followed
τ(V) =
τ0
exp
−(V − Vτ kτ) + exp(V −
Vτ kτ)
except for the time constant of IAs and IKRP. The inactivation for these currents, followed
τhAs(V) = 1790 + 2930exp
−(V + 38.2)
282
V + 38.2
28
and
tKRP(V) = 3 ∗ thAs(V)
For numerical integration, we chose a time step of 0.01 ms. The datasets used for the model 
were archival at the time they were shared with researchers from IBM, and no new 
experiments were suggested, designed, or performed based on these models and analyses. 
All simulations were performed using the IBM Neural Tissue Simulator (NTS) (Kozloski 
and Wagner, 2011) on IBM Cloud. NTS executes simulations based on model descriptions 
(written in the Model Description Language) and resource allocation scripts (written in the 
Graph Specification Language), both of which are available in Supplemental Information. 
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The software is experimental, and readers are therefore encouraged to contact the IBM 
authors if interested in using the tool.
We employed an optimization technique to search parameter space of this model. Each 
optimization targeted features extracted from measures taken during experiments under 
differing conditions as reported in Figure 3. Specifically, we optimized the single neuron 
model to reproduce both the Light off and Light on experimental conditions. By first setting 
the extracellular K+ concentrations to 4.5 mM and 7.5 mM, respectively for each condition, 
we guided automatic changes to model conductance parameters toward models that 
replicated both experimental measurements and conditions simultaneously. The 
optimizations accessed and varied 11 parameters, the maximal conductances gNaT, gNaP, 
gNaS, gKDR, gKRP, gKIR, gKA f , gKAs and GHK based permeability coefficients PCl, leak, 
PNa, leak and PK, leak.
The optimization employed the non-dominated sorting (NS) differential evolution (DE) 
algorithm (NSDE) (Deb et al., 2002; Price et al., 2005), previously used to search parameter 
space of compartmental neuron models in Rumbell et al. (2016). To run the algorithm, we 
used a modified version of the BluePyOpt (Van Geit et al., 2016) python framework for 
single neuron optimization. Each parameter set was simulated for 5 s. Trial-and-error was 
used to assess optimization metaparameters such as population size and number of 
generations. A single optimization of ~500 generations of a population of ~100 models took 
approximately ~12 hours of computing time on an X86_64 Intel architecture (2 Ghz, 64 bit, 
56 cores, 128 Gb of RAM). The neuron model error score for each target feature was 
calculated by extracting feature measures and subtracting them from the exact target values 
based on empirical measures and dividing the absolute value of this quantity by a deviation 
variable based on variability of the experimental measures. Dominance ranking according to 
the NS algorithm was used as the first criterion for model selection, and total error was used 
to sort models within dominance ranks. We ran three optimizations, first to validate the 
modified version of the model with specific ion leaks to reproduce MSN model spiking 
features as in the original implementation (Mahon et al., 2000). All of the relevant features 
targeted and parameters thus obtained are reported in Tables S1-S5. A second optimization 
to find a population of parameter sets that reproduced the range of empirically observed 
excitability measures with Light off and on conditions by the two extracellular K+ 
conditions, and third to target several spiking features from one neuron recording to produce 
a more detailed characterization of MSN firing, sufficiently accurate to allow interpolation 
of excitability measures when tested with various extracellular K+ values. We targeted 4 
features for the second optimization: empirical measurements of resting membrane potential 
(RMP) and rheobase (Rh) in both light on and light off conditions, modeled here as 4.5 mM 
K+ and 7.5 mM K+ respectively. Target feature values were chosen as (target value ± 
deviation) 70.0 ± 4.0 (RMP, 4.5 mM K+), 60.4 ± 4.0 (RMP, 7.5 mM K+), 310.23 ± 10.0 pA 
(Rh, 4.5 mM K+), and 200.89 ± 8.10 pA, to approximate the variability around the empirical 
median of these features. These models were also constrained by change in initial RMP 
voltage variability ~0. For this optimization, the NSDE algorithm (Deb et al., 2002; Price et 
al., 2005) used in Rumbell et al. (2016) was modified by subtracting 2.0 from the calculated 
error score for each feature, rounding up to 0.0. This ensured that any feature values 
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calculated from models that lie within two standard deviations of the mean would be 
considered equally acceptable as a potential model of an empirical observation. As this 
meant that any models with all 4 feature values within 2 standard deviations of the target 
mean would have a total error score of 0.0, we used a crowdedness function to sort models 
with equal total error score, calculated as Euclidean distance to the nearest neighbor in 
feature space. This additional selection criterion encouraged the algorithm to find models 
filling the range of acceptable features within 2 standard deviations of the target mean. We 
ran this optimization for 1000 generations with population size 110, simulating 110,000 
unique parameter sets, among which 1119 acceptable models with total error score of 0.0 
were identified. From among these, 20 were selected randomly and their resulting feature 
values displayed in Figure 4B. For the third optimization, we chose 14 features to optimize 
in the models, which characterized measurements of neuron properties (Figure 4) such as 
Rheobase, resting membrane potential, inter-spike interval distributions, action potential 
shape. Here the target feature values were precise and extracted from one empirical 
recording, and the ‘standard deviations’ used here was selected as 5% of the target feature 
value for each feature, except RMP where smaller ‘standard deviation’ values ~0.1 were 
used, to prevent the optimization from entering local minima (Tables S1-S5). As this 
optimization targeted one particular voltage trace, the above method for reducing errors to 
0.0 within 2 standard deviations was not used. We ran this optimization for 5000 generations 
with a population size of 220, testing 1,100,000 unique parameter sets, at which point we 
terminated the optimization and selected the best fitting member of the population to 
demonstrate the voltage traces shown in Figure 4C. This model was then simulated in 
conditions with extracellular K+ between 4.5 and 7.5 mM in increments of 0.5mM, 
demonstrating reliability of the change in excitability produced by this modulation (Figure 
4D).
In vivo multi-unit recordings of neuronal activity—Three weeks following AAV 
microinjection in the dorsolateral striatum, adult 9 week old male C57Bl6N mice were 
anesthetized with isoflurane (3%−5% induction, 1.5% maintenance). Ten minutes after 
injection of a systemic analgesic (carprofen, 5 mg per kg of body weight) mice were placed 
in a stereotaxic frame. Mice were maintained at 37°C at all times using a feedback-
controlled heating pad. Pressure points and incision sites were injected with lidocaine (2%), 
and eyes were protected from desiccation using artificial tear ointment. The skin above the 
skull was incised, a custom-made lightweight metal head holder was implanted on the skull 
using Vetbond (3M) and a recording chamber was built using dental cement (Ortho-Jet, 
Lang). Mice had a recovery period from surgery of five days, during which they were 
administered amoxicillin (0.25 mg per ml in drinking water through the water supply). After 
the recovery period, mice were habituated to head fixation on the spherical treadmill. On the 
day of the recording, mice were anesthetized with isoflurane. To fix the ground wire, a small 
craniotomy (0.5 mm diameter) was made above the right cerebellum and a silver wire was 
implanted at the surface of the craniotomy and fixed with dental cement. A circular 
craniotomy 1 mm in diameter was made at a location above the dorsolateral striatum and the 
mice was allowed to recover from anesthesia. The recording chamber was filled with cortical 
buffer containing (in mM) 135 NaCl, 5 KCl, 1.8 CaCl2 and 1 MgCl2. The head-bar was 
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fixed to a post and the mouse was placed on the spherical treadmill consisting of a ball 
floating on small cushion of air allowing for 2D movement.
All recordings were performed at least two hours after the end of anesthesia, when the 
mouse was alert and could actively behave. A 128-channel silicon nanoprobe was lowered 
into the brain (Shobe et al., 2015). Each nanoprobe had 2 shanks with 64 electrodes on each 
shank. Each shank was 1.05 mm long and 86 μm at its widest point and tapered to a tip. 
Each prong was separated by 400 μm. A multiplexed analog output signal was sent from the 
head stage (Intan Technologies, RHA-2164B) of each probe via thin flexible cables to a 16-
bit analog to digital conversion cards (USB-6356, National Instruments), which sampled 
each signal at a rate of 25 kHz per channel. Signals were then filtered offline and a 
background signal subtraction was performed. Unit clustering was performed using JRClust 
(Jun et al., 2017), a fully-automated method for clustering units based on unit spike 
properties across multiple channels. We only included high-quality units (Butterworth filter 
300–6000 Hz, spikes count > 1000, SNR > 7.0). We performed firing rate analysis in 
MATLAB; we averaged each unit firing rates across 5 trials with 5 s activity bins. For each 
experimental condition a raster graph was plotted by combining all spike times from 5 trials 
for each unit and down sampling in 5:1 ratio.
General reagents—All general chemicals used were from Cayman Chemical, Tocris, 
Thermo-Fisher or Sigma. Other specific reagents and kits are listed in the methods.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data from every experiment represents a minimum of n animals with a balanced number of 
male and female mice. In all the experiments, n was ≥ 4 mice; sample sizes were not 
calculated a priori. For AAV injections, mice were randomly assigned to each experimental 
group. No experimental data points were excluded. Statistical tests were run in OriginPro 
2015. Summary data are presented as mean ± SEM. Note that in some of the graphs, the bars 
representing the s.e.m. are smaller than the symbols used to represent the mean. For every 
dataset, we determined within Origin whether the data were normally distributed or not 
using the Shapiro-Wilk test. For tests of statistical significance, we used parametric tests for 
normally distributed data and non-parametric tests for data that was not normally distributed. 
Paired and unpaired Student’s two-tailed t tests (as appropriate) and two tailed Mann-
Whitney or Wilcoxon paired sign tests were used for most statistical analyses with 
significance declared at P < 0.05. When a statistical test was employed that was not a 
Student’s t test or a Mann-Whitney test for a specific case, then it is stated as such in the 
text. Specific P values are stated in the figures, however, when the P value was less than 
0.001, it is stated as p < 10−3 to save space on the figure panels and text. However, where 
appropriate key statistics are also reported in the text. If the P value was greater than 0.05, 
then it is stated as p > 0.05. The sample size, n, is defined as the number of cells, numbers of 
slices, fields-of-view or numbers of mice depending on the experiment on a case-by-case 
basis.
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DATA AND SOFTWARE AVAILABILITY
The AAV expression vector for ChR2(H134R)-mCherry using the GfaABC1D promoter will 
be available from Addgene (#112496). Data analyses and software guidance is available 
upon request. The MSN model is available from James R. Kozlozki at IBM.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Multiple approaches reveal transient K+ elevations during ChR2 excitation
• ChR2-mediated K+ elevations increase neuronal excitability and cFos 
expression
• Neuronal effects of K+ are recapitulated with a model and in vivo
• Increased K+ may contribute to astrocyte experiments employing ChR2 in 
vivo
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Figure 1. Optical Stimulation of ChR2-Expressing Cells Evokes Transient Elevation of 
Extracellular K+
(A) Representative image showing brain distribution of channelrhodopsin2 (ChR2-YFP; 
green) in a Thy1-ChR2-YFP mouse brain section together with neurofilament (Nflm, red). 
The inset shows strong colocalization of ChR2 and NeuN positive neurons in cortex.
(B) The images show colocalization of ChR2 with Nflm positive axonal tracts in the 
striatum, but not with NeuN or S100β positive neurons and astrocytes.
(C) Pearson’s colocalization correlation coefficient (r) for images such as those shown in 
(B).
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(D) Left: schematic depicting patch-clamp of medium spiny neurons (MSNs) in the striatum. 
Middle: representative current waveforms from MSNs in Thy1-ChR2-YFP or WT mice in 
response to a train of flashes to stimulate corticostriatal axons. Right: peak amplitude of the 
first EPSC upon blue light flashes.
(E) Left: schematic depicting patch-clamp of astrocytes in the striatum. Middle: 
representative current waveforms from striatal astrocytes in Thy1-ChR2-YFP or WT mice in 
response to a train of flashes. Right: quantification of the steady-state inward current (Iss) 
from MSNs and astrocytes in the striatum from WT or Thy1-ChR2-YFP mice.
(F) Left: schematic depicting the experimental setup for recording of K+ dynamics in brain 
slices with blue light activation ofChR2. Right: graph plots the response of the K+ electrode 
to various K+ concentrations in the extracellular fluid.
(G) Left: waveforms of changes in K+ concentration in response to a single flash of various 
light intensities. Right: quantification of the peak amplitude of K+ in WT and Thy1-ChR2-
YFP mice in response to single flashes of various light intensities.
(H) Left: waveform depicting changes in K+ in response to different numbers of flashes in 
Thy1-ChR2 and WT mice. Right: quantification of the peak amplitude of the K+ elevation in 
WT and Thy1-ChR2-YFP mice in response to different numbers of flashes.
(I) Left: waveform depicting K+ responses in the striatum with TTX or TTX, CNQX, and 
APV. Right: average data for experiments in the left panel.
(J) Left: schematic depicting patch-clamp of pyramidal neurons in the cortex. Middle: 
representative voltage waveform in cortical pyramidal cells from WT or Thy1-ChR2 mice 
with light flashes. Right: quantification of the number of action potentials.
(K) Left: quantification of the peak K+ concentration in the cortex. Middle: representative 
waveform of K+ concentrations in the cortex. Right: average data from the experiment 
depicted in the left panel. Data shown as mean ± SEM. In some cases, the error bars are 
smaller than the symbol used to represent the mean. See also Figures S1—S3.
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Figure 2. Transient Extracellular K+ Increases Occur Following AAV-Driven Expression of 
ChR2
(A) AAV vector for neuron-specific expression of ChR2(H134R).
(B) Left: representative image of the dorsolateral striatum showing the colocalization of 
hSyn-ChR2(H134R)-YFP (red) and NeuN (green). Right: representative image of hSyn-
ChR2(H134R)-YFP (red) and S100β (green).
(C) Left: waveforms depicting striatal K+ elevations in mice expressing the hSyn-ChR2. 
Right: average data for hSyn-ChR2(H134R)-YFP K+ elevations.
(D) Left: waveforms of K+ elevations with and without TTX. Right: quantification of 
various properties of the responses shown in the left panel.
(E) AAV vector for astrocyte-specific expression of ChR2(H134R).
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(F) Left: representative image showing the distribution of GfaABC1D-ChR2 showing 
overlap with S100β (green). Right: representative image of the dorsolateral striatum 
showing colocalization of GfaABC1D-ChR2 (red) and NeuN (green).
(G) Left: waveforms of K+ elevations in mice expressing the GfaABC1D-ChR2. Right: 
average data for the experiment in the left panel.
(H) Left: waveform of K+ elevations with and without Ba2+ applied to the slice. Right: 
quantification of various properties of the responses in the left panel.
(I) Representative images from animals expressing ChR2(H134R) in cortical astrocytes, 
showing overlap with S100β in green.
(J) Left: schematic depicting the experimental setup for in vivo monitoring of K+ 
concentrations. Middle: waveforms of K+ concentration changes in the cortex from in vivo 
recordings. Right: average peak K+ concentration in the in vivo recordings. The LED power 
was 0.33 mW/mm2. Data shown as mean ± SEM. In some cases, the error bars are smaller 
than the symbol used to represent the mean.
See also Figures S2 and S4.
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Figure 3. ChR2-Mediated Extracellular K+ Increased Neuronal Excitability
(A) Left: representative image of a striatal section from mice expressing GfaABC1D-
ChR2(H134R) (red), showing overlap with S100β (green). Right: fraction of S100β positive 
cells expressing GfaABC1D-ChR2(H134R) in the dorsolateral striatum.
(B) Left: representative image from mice expressing GfaABC1D-ChR2(H134R) (red), 
showing no overlap with NeuN (green). Right: fraction of NeuN positive cells expressing 
GfaABC1D-ChR2(H134R) in the dorsolateral striatum.
Octeau et al. Page 30
Cell Rep. Author manuscript; available in PMC 2019 June 19.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(C) Left: schematic depicting patch-clamp of medium spiny neurons (MSNs) in the striatum 
near astrocytes expressing ChR2(H134R). Right: waveform of membrane potential changes 
of a MSN to a series of stepwise current injections.
(D) Left: traces of membrane potential changes from MSNs in response to a train of 10 
flashes with and without glutamate antagonists in mice expressing GfaABC1D-ChR2. Traces 
for 30 s of flashes with and without glutamate antagonists are also shown. Right: average 
data from experiments shown with the traces.
(E) Left: waveforms of membrane potential responses of a MSN to a ramp current injection 
with and without blue light. Inset: highlighted region showing rheobase shift. The scatter 
graphs show average data for rheobase and membrane potential.
(F) Left: representative images showing overlap between cFos (upper left inset, white) and 
S100β (lower left inset, red) from animals in which ChR2 was expressed in astrocytes and 
activated with blue light. Right: as in left panels, but for NeuN (green) instead of S100β.
(G) As in (F), but for control experiments expressing tdTomato instead of ChR2.
(H) Summary plots of cFos expression following optical stimulation of astrocytes expressing 
ChR2 in relation to control experiments where astrocytes expressed tdTomato. For the 
experiments in (F)-(H), the stimulation conditions were 0.05 Hz (10 s on and 10 s off for 1 
hr). The power was ~3.5 mW from the tip of the cannula before implantation. Data shown as 
mean ± SEM. In some cases, the error bars are smaller than the symbol used to represent the 
mean.
See also Figures S3 and S4.
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Figure 4. Computational Modeling of K+ Effects In Silico
(A) Diagrammatic representation of the circuit model of a MSN with the indicated active 
conductances and ion-specific leak currents. Key values used in the model are listed in Table 
1: kinetic parameters were unchanged from those reported in published work (Mahon et al., 
2000).
(B) Scatter graphs plot the effect of K+ elevations from 4.5 to 7.5 mM on the MSN model 
population’s resting membrane potentials and rheobases. Each conductance parameter set 
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(model instance) is represented as a pair of points joined by a line. Across scatterplots, 
colors represent the same model instance.
(C) Traces of MSN excitability from the computational model at the indicated levels of K+. 
The arrows emphasize the shift in rheobase with increasing K+.
(D) Summary plots of how resting membrane potential and rheobase change as a function of 
extracellular K+ in the MSN model depicted in (C). Full details of the MSN model are 
provided in the STAR Methods section.
See also Tables S1 — S5.
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Figure 5. In Vivo Activation of ChR2 in Astrocytes Enhances MSN AP Firing Measured with 
Silicon Probes in Awake Behaving Mice
(A) Schematic depicting experimental workflow using multi-site silicon probes in vivo. 
Mice were injected with AAVs to express tdTomato or ChR2 within astrocytes. Light flashes 
were produced by 30 s of 25 ms flashes at 20 Hz and at 470 nm using a LED light source.
(B) IHC staining of coronal sections from mice injected with AAVs expressing tdTomato 
(left) or ChR2 (right) in astrocytes of the dorsolateral striatum (white dashed outline) and 
used for in vivo recordings.
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(C) Representative waveforms from narrow spiking single units in either tdTomato (left) or 
ChR2 (right) expressing mice. The average trace is the thick colored line.
(D) Raster plots of single unit recordings from 5 mice expressing tdTomato (top graph) or 
ChR2 (bottom graph) during 30 s periods with the LED off or on.
(E) Average firing rate of all units over the recording period (in 5 s bins) in tdTomato or 
ChR2 groups of mice. The period optical stimulation is highlighted in blue.
(F) Bar graphs of average activity of all units in the 30 s periods prior to, during, or 
following optical stimulation in either condition. Average data are represented as mean ± 
SEM from n = 5 mice.
Octeau et al. Page 35
Cell Rep. Author manuscript; available in PMC 2019 June 19.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Octeau et al. Page 36
Ta
bl
e 
1.
Co
m
pa
ris
on
 o
f C
hR
2-
M
ed
ia
te
d 
Ex
tra
ce
llu
la
r K
+
 
El
ev
at
io
ns
 a
t R
oo
m
 T
em
pe
ra
tu
re
 a
nd
 a
t M
or
e 
Ph
ys
io
lo
gi
ca
l T
em
pe
ra
tu
re
s
# 
Sl
ic
es
 [#
 M
ice
]
Pe
a
k 
C
ha
ng
e i
n 
K
+
 
(m
M
)
R
ise
 T
im
e 
(τ;
 s)
D
ec
ay
 T
im
e 
(τ;
 s)
20
°C
34
° C
20
°C
34
°C
p
20
°C
34
° C
p
20
°C
34
° C
p
Tr
an
sg
en
ic
 m
ou
se
15
 [4
]
18
 [4
]
2.
7 
± 
0.
2
2.
7 
± 
0.
3
0.
55
2.
1 
± 
0.
6
5.
3 
± 
0.
7
<
 0
.0
01
7.
2 
± 
0.
5
14
.4
 ±
 3
.8
0.
07
Th
y1
 
Ch
R2
A
AV
 h
Sy
na
ps
in
1 
Ch
R2
12
 [4
]
16
 [4
]
4.
3 
± 
0.
8
3.
5 
± 
0.
3
0.
29
3.
2 
± 
0.
3
4.
7 
± 
0.
5
0.
02
9.
5 
± 
1.
4
18
.9
 ±
 1
.5
<
 0
.0
01
A
AV
 G
fa
A
BC
1D
 
Ch
R2
16
 [4
]
20
 [4
]
2.
9 
± 
0.
2
2.
7 
± 
0.
1
0.
52
3.
0 
± 
0.
2
2.
9 
± 
0.
3
0.
74
11
.0
 ±
 1
.4
12
.8
 ±
 1
.0
0.
12
Th
e 
pe
ak
 c
ha
ng
e 
in
 K
+
 
co
n
ce
n
tr
at
io
ns
 w
er
e 
no
t s
ig
ni
fic
an
tly
 d
iff
er
en
t a
t r
oo
m
 (2
0°
C)
 ve
rs
u
s 
a 
m
o
re
 p
hy
sio
lo
gi
ca
l t
em
pe
ra
tu
re
 (3
4°
C)
 in
 ac
ute
 sl
ice
 ex
pe
rim
en
ts 
in
 th
e 
str
ia
tu
m
. H
ow
ev
er
,
 
so
m
e 
as
pe
ct
s o
f 
th
e 
ki
ne
tic
s (
τ) 
we
re.
 A
ll v
al
ue
s a
re
 re
po
rte
d 
as
 m
ea
n 
± 
SE
M
 fr
om
 th
e 
nu
m
be
r o
f s
lic
es
 in
di
ca
te
d 
(n)
 fr
om
 4 
mi
ce
 in
 ea
ch
 co
nd
itio
n.
Cell Rep. Author manuscript; available in PMC 2019 June 19.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Octeau et al. Page 37
Ta
bl
e 
2.
M
od
el
 P
ar
am
et
er
s 
U
se
d 
in
 M
SN
 C
om
pu
ta
tio
ns
 S
ho
w
n
 in
 F
ig
ur
e 
4
S ∞
τ(V
)
C
ur
re
n
t
G
at
e
g 
(n
S.μ
m−
2 )
V
s 
(m
V)
k s
 
(m
V)
τ 0 
(m
s)
V
τ (
mV
)
k τ
 
(m
V)
I N
at
m
N
at
3
,
 
h N
at
1.
61
Se
e 
ST
A
R 
M
et
ho
ds
I N
ap
m
N
ap
3.
1e
−
3
−
47
.8
3.
1
1.
0
-
-
I N
as
m
N
as
0.
02
−
16
.0
9.
4
63
7.
8
−
33
.5
26
.3
I K
D
R
n K
D
R
4
0.
11
Se
e 
ST
A
R 
M
et
ho
ds
I K
IR
m
K
IR
0.
33
e−
3
−
10
0
−
10
–
–
–
I K
R
P
m
K
RP
0.
15
5
−
13
.4
12
.1
20
6.
2
−
53
.9
26
.5
h K
RP
−
55
.0
−
19
.0
Se
e 
ST
A
R 
M
et
ho
ds
I K
A
f
m
K
A
f
0.
00
17
−
33
.1
7.
5
1.
0
–
–
h K
A
f
−
70
.4
−
7.
6
25
.0
–
–
I K
A
S
m
K
A
S
6.
7e
−
6
−
25
.6
13
.3
13
1.
4
−
37
.4
27
.3
h K
A
S
−
78
.8
−
10
.4
Se
e 
ST
A
R 
M
et
ho
ds
Fu
ll 
de
ta
ils
 a
re
 in
 th
e 
ST
A
R 
M
et
ho
ds
. H
er
e,
 P
N
a,
 le
ak
 
=
 1
.9
6e
−
7 ,
 
P C
l, 
le
ak
 
=
 1
.5
e−
7 ,
 
an
d 
P K
, l
ea
k 
=
 0
.6
e−
7 (
μm
/m
s).
 T
he
 eq
uil
ibr
ium
 po
ten
tia
ls 
for
 N
a+
,
 
K
+
 
an
d 
Cl
−
 
w
er
e 
56
.6
4 
m
V,
 
−
87
.0
6 
m
V,
 
an
d 
−
95
.0
7 
m
V
 at
 2
95
.1
5 
K
, r
es
pe
ct
iv
el
y,
 
an
d 
w
er
e 
ca
lc
ul
at
ed
 u
sin
g 
th
e 
N
er
ns
t e
qu
at
io
n 
fo
r e
ac
h 
io
n 
w
ith
 c
on
ce
nt
ra
tio
ns
 id
en
tic
al
 to
 th
os
e 
us
ed
 in
 th
e 
ex
pe
rim
en
ts.
Cell Rep. Author manuscript; available in PMC 2019 June 19.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Octeau et al. Page 38
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Chicken anti-GFP Abcam Cat# ab13970; RRID: AB_300798
Rabbit anti-NeuN Cell Signaling Cat# 12943; RRID: AB_2630395
Mouse anti-mCherry Saint John’s Cat#STJ97087; RRID:AB_2687534
Rabbit anti-DsRed Clontech Laboratories Cat# 632496; RRID:AB_10013483
Rabbit anti-S100b Abcam Cat# ab41548; RRID: AB_956280
Guinea pig anti-Neun Synaptic Systems Cat# 266 004; RRID:AB_2619988
Guinea pig anti-cFOS Synaptic Systems Cat# 226 004; RRID:AB_2619946
Rabbit anti-cFOS Abcam Cat# ab190289; RRID:AB_2737414
Mouse anti-neurofilament Biolegend Cat# SMI-312R; RRID:AB_2314906
Alexa goat anti-rabbit 488 Molecular Probes Cat# A11008; RRID: AB_143165
Alexa goat anti-chicken 488 Molecular Probes Cat# A11039; RRID: AB_142924
Alexa goat anti-rabbit 546 Molecular Probes Cat#A11010; RRID: AB_143156
Alexa goat anti-mouse 546 Molecular Probes Cat#A11003; RRID: AB_141370
Alexa goat anti-guinea pig 488 Molecular Probes Cat# A-11073; RRID:AB_142018
Alexa goat anti-guinea pig 546 Molecular Probes Cat# A-11074 RRID:AB_2534118
Bacterial and Virus Strains
AAV2/5 GfaABC1D ChR2(H134R)-mCherry SV40 This manuscript, UPenn Vector Core Available upon request from UPenn
AAV2/1 hSynapsinl ChR2(H134R)-eYFP SV40 UNC GTC vector core Lot# AV4319J
Chemicals, Peptides, and Recombinant Proteins
TTX Cayman Chemical Company Cat# 14964
CNQX Tocris Cat# 0190
D-AP5 Tocris Cat# 0106
Barium chloride Sigma Cat# 202738
Normal goat serum Vector Cat# S-1000
Critical Commercial Assays
QIAquick PCR Purification Kit QIAGEN Cat# 28104
QIAGEN Mini kit QIAGEN Cat# 27104
QIAGEN Endofree MAXI kit QIAGEN Cat# 12362
QIAquick Gel extraction Kit QIAGEN Cat# 28704
Experimental Models: Organisms/Strains
Mouse: C57BL/6N inbred mice Taconic JAX Stock # 005304
Mouse: Thy1-ChR2-YFP Arenkiel et al., 2007 JAX Stock # 007615
Recombinant DNA
pZac2.1 GfaABC1D ChR2(H134R) SV40 This manuscript; Addgene Plasmid # 112496
Software and Algorithms
OriginPro 8.5/9/2015 Origin Lab N/A
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REAGENT or RESOURCE SOURCE IDENTIFIER
GraphPad Instat 3 GraphPad Software N/A
pCLAMP10 Molecular Devices N/A
ClampFit 10.5 Molecular Devices N/A
Fluoview FV3000 Olympus N/A
ImageJ v1.30 ImageJ N/A
ANY-maze behavioral tracking software Stoelting Co. N/A
Prizmatix Pulser Prizmatix Ltd. N/A
MSN model parameter file GSL file submitted here N/A
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